For Medspa Owners / Pricing Benchmarks
What to charge.
Pricing benchmarks from 1,202 treatment-evidence GLP-1 clinic records in the GLP1Search directory. Regional medians, percentile distributions, cost structure, and margin math.
National Benchmarks
$500/mo
25th percentile — budget tier
$500/mo
Median — national mid-market
$500/mo
75th percentile — premium
1,202
Clinic data points
Pricing by state
Top 10 states by clinic count. Use these as starting benchmarks for your market.
| State | Clinics | Median $/mo | Min–Max |
|---|---|---|---|
| California | 228 | $500 | $250–$500 |
| Colorado | 124 | $500 | $500–$500 |
| Texas | 102 | $500 | $500–$500 |
| Tennessee | 92 | $500 | $500–$500 |
| Georgia | 91 | $500 | $500–$500 |
| Arizona | 77 | $500 | $299–$500 |
| Florida | 58 | $500 | $249–$500 |
| Pennsylvania | 57 | $500 | $299–$500 |
| Massachusetts | 44 | $500 | $299–$500 |
| Washington | 37 | $500 | $500–$500 |
Cost structure
A typical compounded-semaglutide program's unit economics break down as: COGS (pharmacy fill) 25–40% of revenue, clinical labor 10–18%, platform/software 3–6%, ad spend 15–25%, overhead and payment processing 5–8%, leaving 20–35% contribution margin before fixed costs. Compounded tirzepatide is similar with slightly higher COGS.
Compounded vs. brand economics
Compounded GLP-1 programs have roughly 3–5x the gross margin of brand programs at similar price points, but compounded availability is tied to FDA shortage-list status. Operators who depend entirely on compounded revenue should model for brand-only months and build a brand-dispensing workflow in advance.
Premium vs. budget positioning
Premium positioning ($500+/mo) requires differentiators: MD-supervised care, on-site labs, body composition tracking, dietitian/coach access, or concierge scheduling. Budget positioning (sub-$500/mo) works best at high volume with tight labor — usually NP-led, asynchronous-first, minimal ancillary services.